Markets:

Overview

News

Currencies

International

Treasuries

Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)

5.250 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aldeyra Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 01, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 01, 2023

Via Benzinga

Expert Ratings for Aldeyra Therapeutics ↗

August 09, 2023

Via Benzinga

Analyst Ratings for Aldeyra Therapeutics ↗

June 22, 2023

Via Benzinga

Recap: Aldeyra Therapeutics Q1 Earnings ↗

May 04, 2023

Via Benzinga

What's Going On With Aldeyra Therapeutics Stock? ↗

November 01, 2023

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares are trading higher Wednesday after the company announced that it entered into an exclusive opti

Via Benzinga

Why Are Stocks Up Today? ↗

November 01, 2023

Stocks are up today as investors prepare for the most recent information from the Federal Reserve concerning interest rates.

Via InvestorPlace

Topics Economy

Why Is Aldeyra Therapeutics (ALDX) Stock Up 40% Today? ↗

November 01, 2023

Aldeyra Therapeutics stock is rising with heavy trading of ALDX shares after signing an exclusive option agreement with AbbVie.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 01, 2023

Via Benzinga

Crude Oil Moves Lower; Consolidated Communications Shares Jump ↗

October 16, 2023

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Monday. The Dow traded up 0.93% to 33,983.22 while the NASDAQ rose 1.31% to 13,582.67. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023 ↗

October 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 16, 2023

Via Benzinga

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 16, 2023

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Via Benzinga

Nasdaq Gains 1%; Charles Schwab Earnings Top Views ↗

October 16, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&P...

Via Benzinga

Topics Stocks

Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October ↗

October 16, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.72% to 33,913.22 while the NASDAQ rose 0.46% to 13,468.82. The S&P 500 also...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 16, 2023

Via Benzinga

Why Aldeyra Therapeutics (ALDX) Stock Is Getting Obliterated ↗

October 16, 2023

Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares are trading lower by 62% to $2.07 during Monday's pre-market session. The company on Monday morning received feedback from the U.S.

Via Benzinga

Manchester United, Trip.com Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

September 05, 2023

U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Aldeyra Therapeutics' Chronic Cough Potential Shows Significant Reduction In Cough Frequency Versus Placebo ↗

June 27, 2023

Aldeyra Therapeutics Inc (NASDAQ: ALDX) announced top-line results from the Phase 2 clinical trial of ADX‑629, an investigational new drug administered orally to

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 21, 2023

Via Benzinga

Why Are Aldeyra Therapeutics Shares Plummeting Today ↗

June 21, 2023

Aldeyra Therapeutics Inc (NASDAQ: ALDX) has received a Complete Response Letter from the FDA for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection) for

Via Benzinga

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 15, 2023

Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.

Via Benzinga

Why Aldeyra Therapeutics Stock Is Trading Higher Today ↗

June 15, 2023

Aldeyra Therapeutics Inc (NASDAQ: ALDX) reported topline results from the Phase 3 INVIGORATE-2 trial of 0.25% reproxalap ophthalmic solution, an investigational new drug, in

Via Benzinga

Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday ↗

June 15, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 01, 2023

Via Benzinga

The Week In Charts: 0DTE Options - Too Good To Be True? ↗

April 30, 2023

Zero-days; how Core Methodology can be used in Crypto, with current Crypto and stock market conditions; favorite stock picks.

Via Talk Markets

Short Volatility Alert: Aldeyra Therapeutics ↗

April 28, 2023

On Thursday, shares of Aldeyra Therapeutics (NASDAQ: ALDX) experienced volatile short activity. After the activity, the stock price went down -0.22% to $9.05. The overall sentiment for ALDX has been...

Via Benzinga

OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay ↗

April 18, 2023

Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA).

Via Benzinga

Chart Of The Day: Aldeyra - Skyrocketing ↗

April 11, 2023

Revenue is expected to grow by 2,045.80% next year. Earnings are estimated to increase by 16.90% next year and continue to compound at an annual rate of 73.70% for the next 5 years.

Via Talk Markets

OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4 ↗

March 28, 2023

Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug,...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)

Headline News about Aldeyra Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today